Green Cross Cell rises 9.76% amid umbilical cord blood theme uptrend

On the 16th, the cord blood theme rose 3.49% compared to the previous day, showing strength, while Green Cross Cell, a related stock drawing attention, surged 9.76% compared to the previous day. Green Cross Cell is known as a developer and manufacturer of anticancer immune cell therapies.

[Graph] Price Fluctuations of Major Stocks in the Cord Blood Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross Cell's quant financial score is 23.7 points, with higher stability and profitability scores than the average of other cord blood-related stocks, but its quant financial ranking was only 4th out of 7 stocks. On the other hand, Green Cross achieved the 1st place in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Scores within the Theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.